Intravenous Vitamin C Kills Cancer Cells

September 14, 2005

Bill Sardi | September 14 2005

Recall how hydrogen peroxide is poured on wounds to kill germs. Well

now researchers clearly show high-dose vitamin C, when administered

intravenously, can increase hydrogen peroxide (H2O2) levels within

cancer cells and kills them. I.V. vitamin C was also demonstrated to

kill germs and may be an effective therapy for infectious disease.

With a growing body of evidence mounting, National Institutes of

Health (NIH) researchers conceded today that intravenous vitamin C may

be an effective treatment for cancer. Last year the same researchers

reported a similar study but the news media failed to publish it.

The latest study, published in the Proceedings of the National Academy

of Sciences, confirms the work of Nobel-Prize winner Dr. Linus Pauling

who conducted cancer research in the 1970s with vitamin C. Dr.

Pauling's studies were discredited at the time by poorly conducted

research studies at the Mayo Clinic.

Unlike cancer drugs, I.V. vitamin C selectively killed cancer cells,

but not healthy cells, and showed no toxicity. The ability of

intravenous vitamin C to kill lymphoma cells was remarkable – almost

100% at easily achievable blood serum concentrations.

For inexplicable reasons, NIH researchers continue to maintain

high-dose oral vitamin C can produce a limited increase in serum

vitamin C concentrations. However, their earlier study published in

2004 clearly showed oral-dose vitamin C can achieve three times

greater blood concentration than previously thought possible, a fact

which negates the current Recommended Dietary Allowance for vitamin C.

[Annals Internal Medicine 140:533–7, 2004] NIH researchers refuse to

issue a retraction of their earlier flawed research which mistakenly

claimed humans cannot benefit from high-dose oral vitamin C supplements.

The NIH also offered no explanation why it has taken 35 years to

confirm the work of Dr. Linus Pauling.

Recommended Posts